Targeting the part of the brain that regulates appetite and food intake creates a feeling of satiety that curbs your appetite and signals you to feel full
Wegovy is indicated for people ages 12 years and older who have: A BMI of 30 kg/m 2 or higher A BMI of 27 kg/m 2 to 29.9 kg/m 2 and at least one weight-related comorbidity , such as high blood pressure, type 2 diabetes, or obstructive sleep apnea Wegovy is also indicated to reduce the risk of major cardiovascular events , such as heart attack or stroke, in people who have obesity or overweight
8 weeks (early titration): ~1 vial 16 weeks (up to 1.7 mg): ~1 vial 20+ weeks (2.4 mg maintenance): ~2 vials Insulin Syringes (U-100, 1 mL) Per week: 1 syringe (once-weekly dosing) 12 weeks: 12 syringes 24 weeks: 24 syringes 48 weeks: 48 syringes Bacteriostatic Water (10 mL bottles) Use 3.0 mL per vial for reconstitution
Rx are up to a medical providers discretion
Sodhi said hes concerned that an increasing number of diabetes drugs are being used off-label for weight loss, including Rybelsus, which Health Canada approved in 2020
